Around 25,000 people die in the European Union each year from infections resistant to antibiotics. Third-generation cephalosporins are often useless against common bacteria like Escherichia coli, and fluoroquinolones are no longer the treatment of choice for gonorrhoea because resistance has become widespread. Here, you can find news stories and articles about the issue.
The author of a landmark report on antimicrobial resistance has accused the UK government of losing focus on the challenge over the past 18 months
Effective management of antibiotics can halve the number of people who contract drug-resistant infections in hospital, to mark World Antibiotic Awareness Week, which ran from 13 to 19 November 2017
A new video from the Royal Pharmaceutical Society showcases the diversity of antimicrobial stewardship activities across the pharmacy sector.
Patients will be required to undergo a blood test to decide if they require antibiotics to treat their symptoms as part of a pilot scheme in the north of England.
Antimicrobial resistance — the ability of previously sensitive microorganisms to resist the effects of an antimicrobial agent — is a growing problem. The World Health Organization has warned that we could be moving into a post-antibiotic era where even minor injuries could lead to life-threatening infections, consequently putting an end to complex surgery and returning us to an era where childbirth is high-risk.
Fluoroquinolones for treating tuberculosisSubscription
Tuberculosis (TB) remains a significant global health and socioeconomic challenge. The duration of current anti-TB therapies, the adverse effects of certain anti-TB drugs and the growing problem of drug-resistant TB on an international scale mean that it is imperative for new, effective and safe treatment regimens to be developed. Fluoroquinolones are a class of drugs that have been used in the treatment of TB for several decades. This article provides an overview of the current treatment ...
There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.
Superbug encounters of the resistant kindSubscription
Superbugs: The Fight For Our Lives, a new exhibition at London’s Science Museum, explores potential solutions to the global threat of antibiotic resistance.
Putting the rise of STIs in England into contextSubscription
Laura Waters explains the rise of STIs in the UK, the possible reasons behind it and possible solutions, and considers the challenges posed by the current economic climate.
AMR: time is running out, we need action nowSubscription
AMR is one of the biggest threats to modern medicine and the global economy, yet millions of people are unaware of its potentially catastrophic implications.
Science reproducibility crisis: better measurement is required to tackle global health challengesSubscription
Measurement underpins UK trade and regulation, and helps us support innovation and government policy.